Cardinal Health, Inc. $CAH Stock Holdings Lessened by Mather Group LLC.

Mather Group LLC. trimmed its stake in Cardinal Health, Inc. (NYSE:CAH) by 2.1% in the second quarter, Holdings Channel.com reports. The firm owned 4,935 shares of the company’s stock after selling 108 shares during the quarter. Mather Group LLC.’s holdings in Cardinal Health were worth $829,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Cardinal Health in the first quarter worth approximately $26,000. Tompkins Financial Corp lifted its position in shares of Cardinal Health by 106.7% in the first quarter. Tompkins Financial Corp now owns 248 shares of the company’s stock worth $34,000 after purchasing an additional 128 shares in the last quarter. GW&K Investment Management LLC lifted its position in shares of Cardinal Health by 113.4% in the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after purchasing an additional 144 shares in the last quarter. NBC Securities Inc. purchased a new stake in shares of Cardinal Health in the first quarter worth approximately $48,000. Finally, Zions Bancorporation National Association UT purchased a new stake in shares of Cardinal Health in the first quarter worth approximately $52,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

CAH has been the topic of several recent research reports. Bank of America raised their price objective on shares of Cardinal Health from $165.00 to $170.00 and gave the company a “buy” rating in a research report on Tuesday, June 10th. Morgan Stanley reaffirmed an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $185.00 price objective (up previously from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Evercore ISI cut their price objective on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 13th. Finally, Robert W. Baird raised their price objective on shares of Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research report on Wednesday, August 13th. Eleven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average price target of $165.93.

Cardinal Health Stock Down 3.6%

Shares of CAH stock opened at $149.04 on Friday. Cardinal Health, Inc. has a 12 month low of $106.98 and a 12 month high of $168.44. The business’s 50 day moving average is $152.31 and its two-hundred day moving average is $149.09. The company has a market cap of $35.41 billion, a PE ratio of 23.11, a price-to-earnings-growth ratio of 1.31 and a beta of 0.73.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter last year, the company posted $1.84 earnings per share. The company’s revenue for the quarter was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.4%. Cardinal Health’s dividend payout ratio (DPR) is presently 31.63%.

Insiders Place Their Bets

In other news, insider Jessica L. Mayer sold 38,078 shares of the firm’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the sale, the insider owned 48,457 shares in the company, valued at approximately $7,211,370.74. This trade represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the sale, the insider owned 15,431 shares in the company, valued at approximately $2,298,293.14. The trade was a 64.59% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 271,676 shares of company stock valued at $40,489,525 in the last 90 days. 0.12% of the stock is currently owned by corporate insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.